| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 6 | -3.87 M | 100% | $11.67 | -$45.1 M |
| Net | -6 | -3.87 M | -100% | -$45.1 M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Skorpios Trust | 10%+ Owner | $126 M | -$41.8 M | -24.9% | Apr 17, 2024 |
| Edward M. MD Kaye | CEO, Director | $2.09 M | -$722 K | -25.7% | May 20, 2024 |
| Stephen Tulipano | Former CFO | $758 K | -$25.1 K | -3.21% | Mar 27, 2024 |
| Barry Ticho | Chief Medical Officer | $665 K | -$736 K | -52.5% | Jul 1, 2024 |
| Huw M. Nash | Chief Business Officer | $631 K | -$1.64 M | -72.2% | Jul 2, 2024 |
| Jonathan Allan | General Counsel & Corp Sec | $418 K | -$211 K | -33.6% | May 20, 2024 |
| Arthur Tzianabos | Director | $69.5 K | Jun 5, 2024 | ||
| Arthur A. Levin | Director | Jun 5, 2024 | |||
| Jennifer Burstein | Director | Jun 5, 2024 | |||
| Seth Loring Harrison | Director | Jun 5, 2024 | |||
| E. Garry Menzel | Director | Jun 5, 2024 | |||
| Julie Smith | Director | Jun 5, 2024 | |||
| ATP Life Science Ventures, L.P. | 10%+ Owner | Jun 28, 2021 | |||
| Thomas Leggett | Chief Financial Officer | May 15, 2024 | |||
| Adrian R. Krainer | Director | Jun 5, 2024 | |||
| Ian F. Smith | Director | Jun 5, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|